CHA
Cooper/Haims Advisors Portfolio holdings
AUM
$203M
This Quarter Return
+6.87%
1 Year Return
+12.72%
3 Year Return
+42.88%
5 Year Return
+78.67%
10 Year Return
–
AUM
$203M
AUM Growth
+$203M
(+10%)
Cap. Flow
+$7.42M
Cap. Flow
% of AUM
3.66%
Top 10 Holdings %
Top 10 Hldgs %
72.35%
Holding
89
New
10
Increased
46
Reduced
13
Closed
4
Top Buys
| 1 |
iShares Core S&P 500 ETF
IVV
|
$2.4M |
| 2 |
JPMorgan Core Plus Bond ETF
JCPB
|
$2.22M |
| 3 |
Vanguard Tax-Exempt Bond Index Fund
VTEB
|
$1.91M |
| 4 |
Schwab US Aggregate Bond ETF
SCHZ
|
$821K |
| 5 |
Schwab Emerging Markets Equity ETF
SCHE
|
$793K |
Top Sells
| 1 |
Kennametal
KMT
|
$4.14M |
| 2 |
L3Harris
LHX
|
$245K |
| 3 |
Eastman Chemical
EMN
|
$234K |
| 4 |
Merck
MRK
|
$223K |
| 5 |
Graham Corp
GHM
|
$201K |
Sector Composition
| 1 | Technology | 11.46% |
| 2 | Industrials | 2.63% |
| 3 | Consumer Discretionary | 1.53% |
| 4 | Financials | 1.47% |
| 5 | Consumer Staples | 1.36% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
76
iShares MSCI EAFE ETF
EFA
$66B
| $215K | 0.11% |
+2,411
| New | +$215K |
|
77
Innovative Industrial Properties
IIPR
$1.59B
| $210K | 0.1% |
+3,803
| New | +$210K |
|
78
iShares iBonds Dec 2028 Term Corporate ETF
IBDT
$3.09B
| $209K | 0.1% |
8,230
| – | – |
|
79
iShares MSCI USA Min Vol Factor ETF
USMV
$23.4B
| $206K | 0.1% |
2,194
| – | – |
|
80
TJX Companies
TJX
$152B
| $205K | 0.1% |
+1,657
| New | +$205K |
|
81
Air Products & Chemicals
APD
$65.5B
| $202K | 0.1% |
715
| – | – |
|
82
Vanguard FTSE All-World ex-US ETF
VEU
$48.6B
| $202K | 0.1% |
+3,000
| New | +$202K |
|
83
Gannett
GCI
$603M
| $92.5K | 0.05% |
25,828
| – | – |
|
84
Transocean
RIG
$2.86B
| $28.5K | 0.01% |
11,000
| – | – |
|
85
Tilray
TLRY
$1.52B
| $17.5K | 0.01% |
+42,250
| New | +$17.5K |
|
|
86
Eastman Chemical
EMN
$8.08B
| – | – |
-2,658
| Closed | -$234K |
|
|
87
Graham Corp
GHM
$538M
| – | – |
-6,984
| Closed | -$201K |
|
|
88
L3Harris
LHX
$51.9B
| – | – |
-1,169
| Closed | -$245K |
|
|
89
Merck
MRK
$210B
| – | – |
-2,485
| Closed | -$223K |
|